Association of ongoing drug and alcohol use with non-adherence to antiretroviral therapy and higher risk of AIDS and death: results from ACTG 362COHN, Susan E; HONGYU JIANG; ALLEN MCCUTCHAN, J et al.AIDS Care (Print). 2011, Vol 23, Num 6, pp 775-785, issn 0954-0121, 11 p.Article

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 100-300 CD4⁺ T cellsDE BOER, Alberdina W; MARKOWITZ, Norman; LANE, H. Clifford et al.Clinical immunology (Orlando, Fla. Print). 2003, Vol 106, Num 3, pp 188-196, issn 1521-6616, 9 p.Article

Hematologic, Hepatic, Renal, and Lipid Laboratory Monitoring After Initiation of Combination Antiretroviral Therapy in the United States, 2000―2010YANIK, Elizabeth L; NAPRAVNIK, Sonia; KAHN, James et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 2, pp 216-220, issn 1525-4135, 5 p.Article

Incidence of Non-AIDS-Defining Cancer in Antiretroviral Treatment-Naïve Subjects after Antiretroviral Treatment Initiation: An ACTG Longitudinal Linked Randomized Trials AnalysisKRISHNAN, Supriya; SCHOUTEN, Jeffrey T; JACOBSON, Denise L et al.Oncology. 2011, Vol 80, Num 1-2, pp 42-49, issn 0030-2414, 8 p.Article

Relationship Between CD4⁺ T-Cell Counts/HIV-1 RNA Plasma Viral Load and AIDS-Defining Events Among Persons Followed in the ACTG Longitudinal Linked Randomized Trials StudySMURZYNSKI, Marlene; KUNLING WU; BENSON, Constance A et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 1, pp 117-127, issn 1525-4135, 11 p.Article

Short-term ezetimibe is well tolerated and effective in combination with statin therapy to treat elevated LDL cholesterol in HIV-infected patientsCHOW, Dominic; CHEN, Huichao; GLESBY, Marshall J et al.AIDS (London). 2009, Vol 23, Num 16, pp 2135-2143, issn 0269-9370, 9 p.Article

Proteinuria, Creatinine Clearance, and Immune Activation in AntiretroviralNaive HIV Infected SubjectsGUPTA, Samir K; KOMAROW, Lauren; GULICK, Roy M et al.The Journal of infectious diseases. 2009, Vol 200, Num 4, pp 614-618, issn 0022-1899, 5 p.Article

HIV suppression by HAART preserves cognitive function in advanced, immune-reconstituted AIDS patientsMCCUTCHAN, J. Allen; WU, Julia W; WILLIAMS, Paige L et al.AIDS (London). 2007, Vol 21, Num 9, pp 1109-1117, issn 0269-9370, 9 p.Article

Plasma HiV-1 RNA dynamics in antiretroviral-naive subjects receiving either triple-nucleoside or efavirenz-containing regimens : ACTG A5166s. CommentaryMARKOWITZ, Martin; PERELSON, Alan S; MEYER, William A et al.The Journal of infectious diseases. 2007, Vol 195, Num 8, issn 0022-1899, 1087-1088,1169-1176 [10 p.]Article

Safety of discontinuation of maintenance therapy for disseminated histoplasmosis after immunologic response to antiretroviral therapyGOLDMAN, Mitchell; ZACKIN, Robert; OWENS, Susan et al.Clinical infectious diseases. 2004, Vol 38, Num 10, pp 1485-1489, issn 1058-4838, 5 p.Article

Prevalence of fluconazole-resistant strains of Candida albicans in otherwise healthy outpatientsHABERLAND-CARRODEGUAS, Christel; ALLEN, Carl M; BECK, F. Michael et al.Journal of oral pathology & medicine. 2002, Vol 31, Num 2, pp 99-105, issn 0904-2512Article

Evidence for risk stratification when monitoring for toxicities following initiation of combination antiretroviral therapyTAIWO, Babafemi; YANIK, Elizabeth L; KAHN, James S et al.AIDS (London). 2013, Vol 27, Num 10, pp 1593-1602, issn 0269-9370, 10 p.Article

Evaluation of high-protein supplementation in weight-stable HIV-positive subjects with a history of weight loss : a randomized, double-blind, multicenter trialSATTLER, Fred R; RAJICIC, Natasa; MULLIGAN, Kathleen et al.The American journal of clinical nutrition. 2008, Vol 88, Num 5, pp 1313-1321, issn 0002-9165, 9 p.Article

Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratioMULLIGAN, Kathleen; YANG YANG; WININGER, David A et al.AIDS (London). 2007, Vol 21, Num 1, pp 47-57, issn 0269-9370, 11 p.Article

Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppressionGULICK, Roy M; LALAMA, Christina M; KLINGMAN, Karin L et al.AIDS (London). 2007, Vol 21, Num 7, pp 813-823, issn 0269-9370, 11 p.Article

Three- vs four-drug antiretroviral regimens for the initial treatment of HIV-1 infection : A randomized controlled trialGULICK, Roy M; RIBAUDO, Heather J; MURPHY, Robert L et al.JAMA, the journal of the American Medical Association. 2006, Vol 296, Num 7, pp 769-781, issn 0098-7484, 13 p.Article

Third-trimester maternal toxicity with nevirapine use in pregnancyJOY, Saju; POI, Ming; HUGHES, Laura et al.Obstetrics and gynecology (New York. 1953). 2005, Vol 106, Num 5, pp 1032-1038, issn 0029-7844, 7 p., 1Article

Absence of Sustained hyperlactatemia in HIV-infected patients with risk factors for mitochondrial toxicityWOHL, David A; PILCHER, Christopher D; KASHUBA, Angela et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 3, pp 274-278, issn 1525-4135, 5 p.Article

Long-term follow-up of HIV-infected individuals who have significant increases in CD4⁺ cell counts during antiretroviral therapyKOLETAR, Susan L; WILLIAMS, Paige L; WU, Julia et al.Clinical infectious diseases. 2004, Vol 39, Num 10, pp 1500-1506, issn 1058-4838, 7 p.Article